Posts by John

Biogen confirms the acquisition of RayThera to expand its immunology pipeline. Discover how this strategic move strengthens its position in autoimmune therapy.

A new clinical trial is testing a fully implantable BCI for advanced ALS patients, aiming to restore communication through direct neural signal decoding.

The FDA has extended the public feedback period for its AI medical device pilot program, aiming to refine regulations for machine learning in healthcare.

Clinical AI often hits a performance wall in real-world hospitals. Discover the core challenges of data bias and integration, and how to fix them for success.

In a milestone for medicine, a drug designed by AI has entered human trials. Discover how this innovative approach could change Parkinson's treatment.

UniQure is set to re-engage the FDA for its Huntington’s disease gene therapy, aiming to overcome previous regulatory hurdles with new clinical data.

uniQure eyes FDA approval for AMT-130, a breakthrough gene therapy for Huntington’s disease. Learn the latest on this potential genetic treatment.

A major medical milestone as the first human receives a wireless Paradromics BCI, designed to restore communication for those with speech impairments.

A new liver-targeted insulin shows potential to improve Type 1 Diabetes management by reducing hypoglycemia risks. Discover how this therapy mimics nature.

VahatiCor has enrolled the first U.S. patient in the SERRA-I trial, testing the A-FLUX Reducer System® to treat Coronary Microvascular Dysfunction (CMD).